drugset / Trial / NCT04560738
A Study to Evaluate the Metabolism and Excretion of [14C]-CC-92480 in Healthy Male Participants
NaSingle-groupOpen-labelOther
Summary
This is a single-center, open-label study to be conducted in healthy adult male participants. This study is designed to characterize the biotransformation and excretion of \[14C\]-CC-92480 and to evaluate the safety and tolerability of \[14C\]-CC-92480 following a single oral dose of \[14C\]-CC-92480.
Timeline
- Start
- 2020-10-15
- Primary completion
- 2021-05-13
- Completion
- 2021-05-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mezigdomide | Small molecule | — | Oral |
Indications
No indication recorded.